Kyriakie Sarafoglou, MD

Dr. Kyriakie Sarafoglou is an Associate Professor who holds appointments in the Department of Pediatrics -- Divisions of Endocrinology and Genetics & Metabolism, University of Minnesota Medical School; and the Department of Experimental & Clinical Pharmacology, University of Minnesota College of Pharmacy. She is active in clinical research, patient care, and the education of medical students, pediatric residents, medical scientists, and post-doctoral trainees. Dr. Sarafoglou specializes in rare endocrine and metabolic disorders holding multidisciplinary clinics that care for patients with congenital adrenal hyperplasia and disorders of sex development, hypophosphatasia, Turner syndrome, and inborn errors of metabolism (e.g. congenital disorders of glycosylation). Her research is funded by the National Institutes of Health, Food and Drug Administration, March of Dimes, and industry. Her critically acclaimed textbook published by McGraw Hill, Pediatric Endocrinology and Inborn Errors of Metabolism, is currently in its 2nd Edition and includes 140 contributors from 18 countries, covering approximately 700 endocrine and metabolic disorders.

• Minneapolis - St. Paul "Top Doctors" (2018-2022)
• Minnesota Monthly “Top Doctors” (2016-2019, 2021)
• Clinical/Translational Paper of the Year (Assistant Professor), Department of Pediatrics, University of Minnesota (2015)
• Excellence in Clinical Care Award, University of Minnesota (2015)
• Best Doctors in America® (2011-2020)

Congenital Adrenal Hyperplasia

Adrenal and intersex disorders; Disorders of pubertal development; Inborn errors of metabolism

• Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS (2014). Impact of hydrocortisone on adult height in congenital adrenalhyperplasia. Journal of Pediatrics 164, 1141-1146.